7.15
2.99%
-0.22
Cryo Cell International Inc Azioni (CCEL) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-02-29 | 2023-11-30 | 2023-08-31 | 2023-05-31 | 2023-02-28 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
0.31%
7.8522
|
7.8767 | 7.8699 | 7.7727 | 7.8244 |
Cost Of Revenue |
4.09%
2.1605
|
2.0756 | 2.1562 | 2.1432 | 2.0674 |
Gross Profit |
1.89%
5.6918
|
5.8011 | 5.7137 | 5.6295 | 5.7571 |
Operating Expenses
|
77.84%
4.8705
|
21.98 | 4.5526 | 4.6016 | 4.0739 |
Interest Income/Expense |
251.72%
0.2565
|
-0.169 | 0.4696 | 0.47 | 0.4662 |
Benefits Costs and Expenses |
70.43%
7.0577
|
23.87 | 6.8023 | 7.4263 | 6.6099 |
Costs And Expenses |
70.77%
7.031
|
24.05 | 6.7088 | 6.7448 | 6.1412 |
Depreciation and Amortization |
88.19%
0.0332
|
0.281 | 0.2813 | 0.2811 | 0.2808 |
Operating Income/Loss |
105.08%
0.8212
|
-16.18 | 1.161 | 1.0279 | 1.6832 |
Nonoperating Income/Loss |
114.59%
-0.0267
|
0.1831 | -0.0934 | -0.6815 | -0.4686 |
Income/Loss From Continuing Operations Before Tax |
104.97%
0.7945
|
-15.99 | 1.0676 | 0.3464 | 1.2145 |
Income Tax Expense/Benefit |
104.96%
0.2383
|
-4.803 | 0.3871 | 0.1254 | 0.4477 |
Income/Loss From Continuing Operations After Tax |
104.97%
0.5562
|
-11.19 | 0.6806 | 0.221 | 0.7668 |
Net Income/Loss
|
104.97%
0.5562
|
-11.19 | 0.6806 | 0.221 | 0.7668 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
46,208%
8.2778
|
-0.018 | 8.2866 | 8.3251 | 8.4671 |
Diluted Average Shares |
24,514%
8.325
|
-0.0341 | 8.3421 | 8.3319 | 8.4747 |
Basic Earnings Per Share |
105.22%
0.07
|
-1.34 | 0.08 | 0.03 | 0.09 |
Diluted Earnings Per Share |
105.22%
0.07
|
-1.34 | 0.08 | 0.03 | 0.09 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):